Skip to content

Human Hoxa1 Syndromes Cn381531

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder affecting early development of the brainstem, inner ear, and heart. Children may have developmental delays, hearing loss, and facial or heart abnormalities. Treatment focuses on managing specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

!

Cranial nerve palsy

Bilateral sensorineural hearing loss

(neurological)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Autism spectrum disorder

(psychiatric)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corrective surgical interventions

Surgical repair of congenital anomalies associated with HOXA1 syndromes including ear reconstruction, cleft palate repair, and cardiovascular defect correction when indicated.

surgical
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multisystem surveillance program

Comprehensive regular monitoring for cardiac, auditory, and developmental abnormalities throughout life to identify and address complications early.

monitoring

Additional treatment options

Early intervention services

Developmental therapy services including speech, occupational, and physical therapy initiated early to maximize functional outcomes and address neurodevelopmental concerns.

psychological

Adaptive support strategies

Environmental modifications, assistive devices, and educational accommodations to support individuals with motor, auditory, or cognitive challenges.

lifestyle

Symptomatic pharmaceutical management

Medications for associated symptoms such as reflux disease, constipation, or behavioral concerns may be necessary and should be tailored to individual needs.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Human Hoxa1 Syndromes Cn381531?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Human Hoxa1 Syndromes Cn381531. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy